In OCC 2026 Quest for Truth roundtable, leading cardiovascular experts gather to discuss “Innovation: The Voyage Begins — From Chinese Stents to the Eastern Power in Global Cardiovascular Innovation”. The session is hosted by Prof. Gang Wu, Shanghai General Hospital, and co-moderated by Prof. Qixia Jiang, Shanghai General Hospital. Quest for Truth is honored to welcome the distinguished interview guest: Dr. Fernando Alfonso, Hospital Universitario de la Princesa.
In this segment, the discussion looks beyond coronary intervention toward pan-vascular care and prevention. Prof. Gang Wu asks whether the next wave of cardiovascular innovation will come from refining interventional devices, or from integrating prevention, diagnosis, and intervention across the entire vascular system.
Dr. Fernando Alfonso explains that cardiovascular medicine still often reacts to disease at a very late stage, when patients already have advanced cardiovascular disease. For him, prevention is essential, and new tools are needed to detect and slow disease progression earlier. He highlights non-invasive imaging technologies, especially photon-counting CT, as a promising advance that may provide high-resolution visualization not only of large vessels but also of the coronary arteries, potentially challenging the resolution of some interventional imaging techniques.
When asked about the ultimate mission of innovation, Dr. Alfonso emphasizes that innovation should advance the understanding of cardiovascular disease, which remains the leading cause of mortality worldwide. Its purpose is not innovation for its own sake, but to delay, prevent, and fight cardiovascular disease more effectively, helping patients before disease reaches its most advanced stages.